Envestnet Asset Management Inc Ultragenyx Pharmaceutical Inc. Transaction History

Envestnet Asset Management Inc

$299 Billion
Q1 2025

A detailed history of Envestnet Asset Management Inc transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 28,258 shares of RARE stock, worth $1.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,258

Previous 34,288 17.59%

Holding current value

$1.1 Million

Previous $1.44 Million 29.06%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 29, 2025	SELL	$36.21 - $45.78 $218,346 - $276,053	-6,030 Reduced 17.59%	28,258 $1.02 Million
Q4 2024 Feb 12, 2025	SELL	$42.07 - $57.72 $119,310 - $163,693	-2,836 Reduced 7.64%	34,288 $1.44 Million
Q3 2024 Nov 06, 2024	BUY	$40.21 - $59.36 $425,582 - $628,266	10,584 Added 39.88%	37,124 $2.06 Million
Q2 2024 Aug 08, 2024	SELL	$37.42 - $51.61 $100,584 - $138,727	-2,688 Reduced 9.2%	26,540 $1.09 Million
Q1 2024 May 13, 2024	SELL	$43.02 - $53.69 $13,250 - $16,536	-308 Reduced 1.04%	29,228 $1.36 Million
Q4 2023 Feb 13, 2024	SELL	$31.73 - $49.19 $200,533 - $310,880	-6,320 Reduced 17.63%	29,536 $1.41 Million
Q3 2023 Nov 13, 2023	BUY	$34.92 - $46.66 $198,171 - $264,795	5,675 Added 18.8%	35,856 $1.28 Million
Q2 2023 Aug 04, 2023	BUY	$37.35 - $52.15 $181,819 - $253,866	4,868 Added 19.23%	30,181 $1.39 Million
Q1 2023 May 11, 2023	BUY	$36.99 - $48.71 $42,612 - $56,113	1,152 Added 4.77%	25,313 $1.02 Million
Q4 2022 Feb 07, 2023	BUY	$33.72 - $46.33 $58,436 - $80,289	1,733 Added 7.73%	24,161 $1.12 Million
Q3 2022 Nov 10, 2022	SELL	$39.96 - $66.14 $72,287 - $119,647	-1,809 Reduced 7.46%	22,428 $929,000
Q2 2022 Aug 03, 2022	BUY	$45.8 - $85.4 $19,236 - $35,868	420 Added 1.76%	24,237 $1.45 Million
Q1 2022 May 04, 2022	BUY	$62.2 - $84.4 $245,005 - $332,451	3,939 Added 19.82%	23,817 $1.73 Million
Q4 2021 Feb 04, 2022	BUY	$73.71 - $87.86 $199,680 - $238,012	2,709 Added 15.78%	19,878 $1.67 Million
Q3 2021 Oct 07, 2021	BUY	$77.92 - $102.4 $187,319 - $246,169	2,404 Added 16.28%	17,169 $1.55 Million
Q2 2021 Aug 04, 2021	SELL	$92.19 - $115.71 $177,650 - $222,973	-1,927 Reduced 11.54%	14,765 $1.41 Million
Q1 2021 May 04, 2021	BUY	$106.9 - $167.73 $768,931 - $1.21 Million	7,193 Added 75.72%	16,692 $1.9 Million
Q4 2020 Feb 02, 2021	BUY	$84.4 - $177.39 $154,367 - $324,446	1,829 Added 23.85%	9,499 $1.32 Million
Q3 2020 Oct 09, 2020	BUY	$72.98 - $90.0 $151,798 - $187,200	2,080 Added 37.21%	7,670 $630,000
Q2 2020 Jul 08, 2020	BUY	$46.91 - $78.22 $31,148 - $51,938	664 Added 13.48%	5,590 $437,000
Q1 2020 Apr 23, 2020	BUY	$33.8 - $62.9 $166,498 - $309,845	4,926 New	4,926 $219,000
Q4 2017 Feb 20, 2018	SELL	$43.54 - $57.32 $12,495 - $16,450	-287 Closed	0 $0
Q3 2017 Nov 13, 2017	SELL	$49.79 - $66.32 $18,372 - $24,472	-369 Reduced 56.25%	287 $15,000
Q2 2017 Aug 14, 2017	BUY	N/A	656	656 $40,000

Others Institutions Holding RARE

# of Institutions

341

Shares Held

84.7M

Call Options Held

675K

Put Options Held

846K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $2.73B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Ultragenyx Pharmaceutical Inc. Transaction History